IYH
iShares U.S. Healthcare ETF
iShares U.S. Healthcare ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Dow Jones U.S. Healthcare Sector Index.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 4.5 B
ASSETS UNDER MGMT
37 bp
EXPENSES
Fund Basics
| Inception date | Jun 12, 2000 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ELI LILLY & CO | 15.7 % |
| JOHNSON & JOHNSON | 9.7 % |
| ABBVIE INC | 7.5 % |
| MERCK & CO. INC. | 5.3 % |
| UNITEDHEALTH GROUP INC | 5.2 % |
| THERMO FISHER SCIENTIFIC INC | 3.8 % |
| AMGEN INC | 3.6 % |
| GILEAD SCIENCES INC | 3.0 % |
| ABBOTT LABORATORIES | 2.8 % |
| PFIZER INC | 2.4 % |
Constituent Breakdown
| Number of holdings | 103 |
| Herfindahl-Hirschman Index | 543 |
| Wgt avg mkt cap (mns) | $403,920 |
| Large cap (>$10bn) | 97.6% |
| Mid cap ($2-10bn) | 1.7% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
| UNITED STATES | 96.7 % | |
| IRELAND | 2.4 % |
Historical Performance
Standardized Performance (as of 10/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 19.5% | 27.9% | 12.0% | 14.4% | 6.1% | 10.7% | 9.3% | 7.1% |
| Dividend Yield | 1.0% | 1.6% | 1.4% | 1.4% | 1.3% | 1.4% | 1.5% | 1.3% |
| Total Returns | 20.5% | 29.4% | 13.4% | 15.7% | 7.4% | 12.1% | 10.8% | 8.5% | Ann. Volatility | 16.9% | 16.5% | 16.9% | 15.2% | 15.5% | 16.9% | 17.2% | 17.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.28 | 5% |
| MSCI EAFE | 0.34 | 10% |
| MSCI Emg Mkts | 0.01 | 0% |
Liquidity Measures
| Avg. volume (000) | 1,103 |
| ADV traded (mns) | $82 |
| Turnover | 1.8% |
| Avg. Bid/Ask (% of price) | 0.02% |
Technical Indicators
| 30d moving avg. (EMA) | $76.15 |
| Relative strength (RSI) | 63 |
| MACD/Signal | 1.56/1.54 |
| Bollinger Bands (Upper/Lower) | $80.46/$73.85 |
| Short interest (% of AUM) | 1.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IYH |
Expenses vs. IYH |
ALTAR Score™ vs. IYH |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR | 91.6% | -29 bp | +0.7% |
| FHLC | Fidelity MSCI Health Care Index ETF | 88.2% | -29 bp | -0.5% |
| VHT | Vanguard Health Care ETF | 88.2% | -28 bp | -0.6% |
| IXJ | iShares Global Healthcare ETF | 68.1% | +1 bp | +0.4% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 59.3% | -24 bp | +0.5% |
| JDOC | JPMorgan Healthcare Leaders ETF | 52.7% | +28 bp | -0.6% |
| HRTS | Tema Heart & Health ETF | 51.2% | +62 bp | -3.7% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 50.9% | +38 bp | -3.4% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 48.2% | +23 bp | +0.3% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 47.7% | +3 bp | +0.9% |
Risk and Returns: IYH vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/20/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.6%
ALTAR SCORE™
47th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,568 funds in the US Equity category with an average
ALTAR Score™ of 5.8% and a standard deviation
of 2.1%. IYH's ALTAR Score™ is approximately -0.1 standard
deviations above the category average. This places IYH in the 47th percentile
among funds in the category.
Sell-Side Consensus
$83.55
PRICE TARGET
+12.4%
UPSIDE